Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 2/20 | 0.44 |
| ▸ | F3 | P13726 | 2/20 | 0.44 |
| ▸ | AHR | P35869 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.43 |
| ▸ | HTR3B | O95264 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.43 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | F11 | P03951 | 1/20 | 0.40 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10852558 | 0.90 | HRH4 (0.41) | F7F3AHRLTA4HNR4A2 | |
| SCHEMBL2105330 | 0.84 | ALDH1A1 (0.61) | ALDH1A1HTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL29770331 | 0.84 | ALDH1A1 (0.61) | ALDH1A1HTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL29822961 | 0.79 | MEN1 (0.32) | ALDH1A1SMN1; SMN2HSD17B10POLBKDM4E | |
| SCHEMBL863229 | 0.79 | MEN1 (0.32) | ALDH1A1SMN1; SMN2HSD17B10POLBKDM4E | |
| SCHEMBL1192946 | 0.79 | F7 (0.47) | F7F3AHRLTA4HNR4A2 | |
| SCHEMBL1171146 | 0.79 | ALDH1A1 (0.53) | F7F3AHRLTA4HNR4A2 | |
| SCHEMBL1155693 | 0.76 | KDM4E (0.30) | SMN1; SMN2POLBKDM4EMEN1MAPT | |
| SCHEMBL229607 | 0.76 | KMT2A (0.44) | ALDH1A1HPGDHSD17B10POLBMEN1 | |
| SCHEMBL13533675 | 0.76 | NOS1 (0.41) | NOS1SMN1; SMN2POLBKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051380-A | Application of additive in lithium battery electrolyte, electrolyte and lithium battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | claimed |
| CN-121238173-B | Diaphragm and battery | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-121394778-B | Diaphragm and battery | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-121282568-B | Diaphragm and battery | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2025071094-A1 | USES OF MERCAPTO FUNCTIONAL COMPOUND HAVING TYROSINASE INHIBITORY ACTIVITY | 부산대학교 산학협력단 | 2025-04-03 | — | — | WO | claimed |
| CN-116410733-A | Composite material and preparation method thereof, photoelectric device and preparation method thereof, and display device | TCL科技集团股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| US-20220016099-A1 | BENZIMIDAZOLE OR BENZOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASE, DIABETES, AND COMPLICATIONS THEREOF | TRINUERO (KR) | 2022-01-20 | — | — | US | claimed |
| WO-2020116742-A1 | BENZIMIDAZOLE OR BENZOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASE, DIABETES, AND COMPLICATIONS THEREOF | 주식회사 트리뉴로 | 2020-06-11 | — | — | WO | claimed |
| US-20040018983-A1 | Antifungal compositions | ACHILLION PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| WO-2003055448-A2 | ANTIFUNGAL COMPOSITIONS | ACHILLION PHARMACEUTICALS, INC. (US) | 2003-07-10 | — | — | WO | claimed |
| US-4587200-A | Photopolymerizable composition comprising an acridine and a heterocyclic thiol compound as a photopolymerization initiator and a photographic process using said photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1986-05-06 | — | — | US | claimed |
| US-4028272-A | Process of polymerization of conjugated diolefins using iron catalysts and sulfur ligands | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-06-07 | — | — | US | claimed |
| CN-122051380-A | Application of additive in lithium battery electrolyte, electrolyte and lithium battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | disclosed |
| CN-121394778-B | Diaphragm and battery | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121261064-B | Battery cell | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-121282568-B | Diaphragm and battery | 珠海冠宇电池股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-4069259-A | Process for preparing organic disulfides | ALLIED CHEMICAL CORPORATION (US) | 1978-01-17 | — | — | US | disclosed |
| US-4028272-A | Process of polymerization of conjugated diolefins using iron catalysts and sulfur ligands | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3976769-A | INSECTICIDE | AIRWICK INDUSTRIES, INC. (US) | 1976-08-24 | — | — | US | disclosed |
| US-3936432-A | AND SULFUR LIGANDSS- OR O-CONTAINING LIGANDS WITH IMINE OR IMIDAZOLE GROUPS; DITHIOOXAMIDES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040018983-A1 | Antifungal compositions | CNBP, ERG28, AEBP2 | F7 4012/4885F3 3831/4885AHR 3431/4885 |
| US-20220016099-A1 | BENZIMIDAZOLE OR BENZOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASE, DIABETES, AND COMPLICATIONS THEREOF | KEAP1, SLC5A1, GCLC | F7 4554/4885F3 1558/4885AHR 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.